Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 96 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ACE
💬1. ACE
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy 6件: Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hyper ... | Enalapril
Enalapril
💬1. ACE
| Enalapril | 6件: 19 19, 46, 66, 113, 210, 222 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ACE
💬2. ACE
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy 6件: Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hyper ... | Lisinopril
Lisinopril
💬2. ACE
| Lisinopril | 7件: 19 19, 46, 49, 66, 67, 113, 222 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ACE
💬3. ACE
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy 6件: Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hyper ... | Perindopril
Perindopril
💬3. ACE
| Perindopril | 4件: 58 58, 113, 167, 222 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
ACE
💬4. ACE
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy 6件: Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hyper ... | Lisinopril
Lisinopril
💬4. ACE
| Lisinopril | 7件: 19 19, 46, 49, 66, 67, 113, 222 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
ACE
💬5. ACE
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy 6件: Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hyper ... | Ramipril
Ramipril
💬5. ACE
| Ramipril | 7件: 46 46, 49, 66, 67, 113, 218, 257 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
ADRA1A
💬6. ADRA1A
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Carvedilol
Carvedilol
💬6. ADRA1A
| Carvedilol | 4件: 57 57, 86, 113, 210 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
ADRA1B
💬7. ADRA1B
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Carvedilol
Carvedilol
💬7. ADRA1B
| Carvedilol | 4件: 57 57, 86, 113, 210 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
ADRA1D
💬8. ADRA1D
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Carvedilol
Carvedilol
💬8. ADRA1D
| Carvedilol | 4件: 57 57, 86, 113, 210 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
ADRA2A
💬9. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬9. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬9. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
ADRA2B
💬10. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬10. ADRA2B
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬10. ADRA2B
|